These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7560855)
41. Progesterone receptor in hepatocellular carcinoma. Correlation with androgen and estrogen receptors. Nagasue N; Kohno H; Yamanoi A; Kimoto T; Chang YC; Nakamura T Cancer; 1991 May; 67(10):2501-5. PubMed ID: 1849788 [TBL] [Abstract][Full Text] [Related]
42. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma. Liu C; Sun L; Xu J; Zhao Y World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790 [TBL] [Abstract][Full Text] [Related]
43. Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection. Dai CY; Lin CY; Tsai PC; Lin PY; Yeh ML; Huang CF; Chang WT; Huang JF; Yu ML; Chen YL J Chin Med Assoc; 2018 Feb; 81(2):155-163. PubMed ID: 29217359 [TBL] [Abstract][Full Text] [Related]
44. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation. Zou WL; Zang YJ; Chen XG; Shen ZY Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848 [TBL] [Abstract][Full Text] [Related]
45. nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Boix L; Bruix J; Campo E; Sole M; Castells A; Fuster J; Rivera F; Cardesa A; Rodes J Gastroenterology; 1994 Aug; 107(2):486-91. PubMed ID: 8039626 [TBL] [Abstract][Full Text] [Related]
46. Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers. Vasuri F; Fittipaldi S; Giunchi F; Monica M; Ravaioli M; Degiovanni A; Bonora S; Golfieri R; Bolondi L; Grigioni WF; Pasquinelli G; D'Errico-Grigioni A J Clin Pathol; 2016 Feb; 69(2):102-8. PubMed ID: 26243063 [TBL] [Abstract][Full Text] [Related]
47. EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma. Noh CK; Wang HJ; Kim CM; Kim J; Yoon SY; Lee GH; Cho HJ; Yang MJ; Kim SS; Hwang JC; Cho SW; Roh J; Kim YB; Kim SJ; Kim BW; Cheong JY Anticancer Res; 2018 Jul; 38(7):4101-4109. PubMed ID: 29970536 [TBL] [Abstract][Full Text] [Related]
48. Survival analysis after liver resection for hepatocellular carcinoma: A consecutive cohort of 1002 patients. Lee EC; Kim SH; Park H; Lee SD; Lee SA; Park SJ J Gastroenterol Hepatol; 2017 May; 32(5):1055-1063. PubMed ID: 27797420 [TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection. Nanashima A; Yano H; Yamaguchi H; Tanaka K; Shibasaki S; Sumida Y; Sawai T; Shindou H; Nakagoe T J Gastroenterol; 2004; 39(2):148-54. PubMed ID: 15069621 [TBL] [Abstract][Full Text] [Related]
50. Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence. Huo TI; Lui WY; Wu JC; Huang YH; King KL; Loong CC; Lee PC; Chang FY; Lee SD World J Surg; 2004 Mar; 28(3):258-62. PubMed ID: 14961198 [TBL] [Abstract][Full Text] [Related]
51. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma. Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942 [TBL] [Abstract][Full Text] [Related]
52. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Hung IF; Poon RT; Lai CL; Fung J; Fan ST; Yuen MF Am J Gastroenterol; 2008 Jul; 103(7):1663-73. PubMed ID: 18616655 [TBL] [Abstract][Full Text] [Related]
53. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection. Chen RX; Xia YH; Cui JF; Xue TC; Ye SL J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235 [TBL] [Abstract][Full Text] [Related]
54. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria. Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636 [TBL] [Abstract][Full Text] [Related]
55. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. Yin F; Han X; Yao SK; Wang XL; Yang HC World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422 [TBL] [Abstract][Full Text] [Related]
57. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis. Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707 [TBL] [Abstract][Full Text] [Related]
58. Analysis of p53 Protein Expression in Hepatocellular Carcinoma. Graur F; Furcea L; Mois E; Biliuta A; Rozs AT; Negrean V; Al Hajjar N J Gastrointestin Liver Dis; 2016 Sep; 25(3):345-9. PubMed ID: 27689199 [TBL] [Abstract][Full Text] [Related]
59. Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis. Santambrogio R; Opocher E; Zuin M; Selmi C; Bertolini E; Costa M; Conti M; Montorsi M Ann Surg Oncol; 2009 Dec; 16(12):3289-98. PubMed ID: 19727960 [TBL] [Abstract][Full Text] [Related]
60. Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant. Mourad MM; Algarni A; Aly MA; Gunson BK; Mergental H; Isaac J; Muiesan P; Mirza D; Perera MT; Bramhall SR Exp Clin Transplant; 2015 Aug; 13(4):333-8. PubMed ID: 26295183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]